Fanuc builds new development centre near Stuttgart
Robotics and automation specialist Fanuc is further expanding its site in Neuhausen close to Stuttgart. The robotics leader is investing more than 20 million euros in a fourth building at the site as well as in a parking garage to accommodate the increased number of employees, customers and business partners. Fanuc has been located in the German Southwest for almost 30 years and is growing steadily. In the past three years, the number of employees at the site has increased by around 100 to about 400. The expansion in Neuhausen near Stuttgart, where the German headquarters and some Europe-wide functions are located, will take place over three years. In the first construction phase, a multi-story parking garage with 270 parking spaces is being built. It will be equipped with a photovoltaic system and e-charging stations for electric cars. Completion is scheduled for spring 2021. In a second step, the previous parking site will be used for the construction of a European development centre. After its completion in 2023, the development centre will provide space for 120 employees. Headquartered in Japan, Fanuc employs more than 7,000 people worldwide with global sales of equivalent to 4.2 billion euros in the past fiscal year.
Roche Diagnostics Automation Solutions GmbH relocates its headquarters in the Stuttgart region
Roche Diagnostics Automation Solutions GmbH is relocating its headquarters to Ludwigsburg close to Stuttgart to create a new basis for future growth, ideas and innovations. At the same time, the first 80 employees have been moving into the new campus in June 2020. This was the starting point for the gradual consolidation of the company’s current three sites in the Stuttgart metropolitan region, which is considered Roche Diagnostics‘ centre of excellence for the development and production of laboratory automation systems. The consolidation of the three sites is expected to be completed by 2022. Roche employs around 16,700 people in Germany in the fields of pharmaceuticals and diagnostics. In Baden-Württemberg, the company is represented at three sites: in Grenzach-Wyhlen (Roche Pharma AG), in Mannheim (Roche Diagnostics GmbH, Roche Diagnostics Deutschland GmbH, Roche Diabetes Care GmbH and Roche Diabetes Care Deutschland GmbH) and in the Stuttgart metropolitan region (Roche Diagnostics Automation Solutions GmbH). Roche is clearly committed to its German sites and has invested more than 2.7 billion euros in these locations over the past five years.